1. World Health Organization. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks: Proposed replacement of TRS 878, Annex 1. WHO/BS/10.2132
2. [Anonymous]. IABs scientific workshop on neurovirulence tests for live virus vaccines, January 31-February 1, 2005, Geneva. Biologicals 2006 Sep;34(3):233-236
3. World Health Organization. Recommendations for the production and control of poliomyelitis vaccine (oral). In: WHO Expert Committee on Biological Standardization. Fiftieth report. Geneva, World Health Organization, 2002, Annex 1 (WHO Technical Report Series, No. 904) [http://www.who.int/biologicals/publications/trs/areas/vaccines/polio/WHO_TRS_904_A1polio_oral.pdf]
4. Dunn G, O’Brien J, Heath A, Chumakov K. Report of the WHO collaborative study to establish a new International Standard and three new International Reference Preparations for the MAPREC test of poliovirus Type 1 (Sabin). WHO/BS/09.2103
5. Amexis G, Oeth P, Abel K, Ivshina A, Pelloquin F, Cantor CR, et al. Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 2001 Oct 9;98(21):12097-12102